Clinical Trials Browser

Phase 2 × Terminated × ADI PEG20 × Clear all

NCT01266018 2022-10-25

Study of ADI-PEG 20 in Patients With Relapsed Sensitive or Refractory Small Cell Lung Cancer

Phase 2 Terminated

22 enrolled 14 charts

Small Cell Lung Carcinoma